0 Комментарии
0 Поделились
221 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Streptozocin Market Advances with Ongoing Oncology Research and Expanding Focus on Rare Cancer TherapeuticsAccording to the latest report published by Data Bridge Market Research, the Streptozocin Market The global streptozocin market size was valued at USD 159.40 million in 2025 and is expected to reach USD 232.83 million by 2033, at a CAGR of 4.85% during the forecast period This Streptozocin Market document encompasses several market aspects such as market estimates and forecasts,...0 Комментарии 0 Поделились 591 Просмотры 0 предпросмотр
-
Breakthrough Therapies and Innovation Trends Reshaping the Cancer Pain Management Solutions Market by 2031The Cancer Pain Management Solutions Market is undergoing rapid transformation as advancements in therapeutics, digital health technologies, and patient-centric care models redefine oncology support systems.The integration of pharmacological treatments, medical devices, and non-invasive therapies continues to expand the scope of pain management strategies across global healthcare systems....0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Cancer Biologics Market Advances with Growing Innovation in Targeted Therapies and Next-Generation BiopharmaceuticalsAccording to the latest report published by Data Bridge Market Research, the Cancer Biologics Market The global cancer biologics market size was valued at USD 122.55 billion in 2024 and is projected to reach USD 195.62 billion by 2032, with a CAGR of 6.02% during the forecast period of 2025 to 2032. An influential Cancer Biologics Market advertising report puts light on the types...0 Комментарии 0 Поделились 455 Просмотры 0 предпросмотр
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Driving Growth & Opportunities in the Global Oncology Small Molecule Drugs Market Through 2031The Oncology Small Molecule Drugs Market is witnessing transformative growth as pharmaceutical innovation accelerates to address the global cancer burden. With therapeutics that can penetrate cellular targets, modulate intracellular pathways, and be administered orally, small molecule oncology drugs are becoming essential components of cancer treatment regimens worldwide. The Oncology Small...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
HER2+ Gastric Cancer Market Advances with Targeted Therapy Innovations and Precision Oncology DevelopmentsAccording to the latest report published by Data Bridge Market Research, the HER2+ Gastric Cancer Market The global HER2+ Gastric Cancer market was valued at USD 1.32 billion in 2024 and is expected to reach USD 1.86 billion by 2032During the forecast period of 2025 to 2032 the market is sly to grow at a CAGR of 4.44% This global HER2+ Gastric Cancer Market report is a wonderful...0 Комментарии 0 Поделились 698 Просмотры 0 предпросмотр
-
Histone Deacetylase Inhibitors Market Advances with Growing Epigenetic Research and Targeted Oncology TherapiesAccording to the latest report published by Data Bridge Market Research, the Histone Deacetylase Inhibitors Market The Global Histone Deacetylase Inhibitors Market was valued at USD 1.3 billion in 2024 and is expected to reach USD 2.3 billion by 2032, at a CAGR of 7.7% during the forecast period The reliable Histone Deacetylase Inhibitors Market research report includes a...0 Комментарии 0 Поделились 627 Просмотры 0 предпросмотр
-
In-Depth Opportunities and Strategic Analysis of Adult Malignant Glioma Therapeutics Market Toward 2031The global oncology landscape continues to evolve rapidly with increasing emphasis on treating complex and life-threatening conditions such as malignant gliomas in adults. Rising prevalence of glioblastoma, coupled with advancements in precision medicine, immunotherapy, and targeted therapies, is significantly reshaping treatment paradigms. The growing need for improved survival outcomes and...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Ipilimumab Market Advances with Expanding Immuno-Oncology Research and Growing Adoption of Targeted Cancer TherapiesAccording to the latest report published by Data Bridge Market Research, the Ipilimumab Market The global Ipilimumab market size was valued at USD 2.14 billion in 2025and is expected to reach USD 4.58 billion by 2033, at a CAGR of 10.00% during the forecast period Global Ipilimumab Market report analyses the key developments taking place with respect to agreements, partnerships,...0 Комментарии 0 Поделились 636 Просмотры 0 предпросмотр
-
Oral Mucositis Drugs Market Advances with Novel Supportive Care Therapies and Growing Oncology Treatment DemandAccording to the latest report published by Data Bridge Market Research, the Oral Mucositis Drugs Market Data Bridge Market Research analyses that the global oral mucositis drugs market which was USD 530.00 million in 2023, would rocket up to USD 896.62 million by 2030, and is expected to undergo a CAGR of 7.80% during the forecast period. This Oral Mucositis Drugs Market research...0 Комментарии 0 Поделились 696 Просмотры 0 предпросмотр
-
Polycythemia Vera Market Expands with Advancements in Targeted Therapies and Personalized Hematology CareAccording to the latest report published by Data Bridge Market Research, the Polycytomia Vera Market The global Polycytomia Vera market size was valued at USD 1.35 billion in 2025and is expected to reach USD 1.99 billion by 2033, at a CAGR of 5.00% during the forecast period The persuasive Polycytomia Vera Market report covers several topics including market trend analysis,...0 Комментарии 0 Поделились 486 Просмотры 0 предпросмотр
Расширенные страницы